https://orcid.org/0000-0002-7958-762X
About the Authors
- Masashi Kumon
-
Contributed equally to this work with: Masashi Kumon, Masahiro Fuwa
Roles Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing
Affiliation Product Development Division, Santen Pharmaceutical Co., Ltd., Nara, Japan
- Masahiro Fuwa
-
Contributed equally to this work with: Masashi Kumon, Masahiro Fuwa
Roles Conceptualization, Investigation, Methodology, Writing – original draft, Writing – review & editing
* E-mail: masahiro.fuwa@santen.com
Affiliation Product Development Division, Santen Pharmaceutical Co., Ltd., Nara, Japan
- Atsushi Shimazaki
-
Roles Conceptualization, Writing – review & editing
Affiliation Product Development Division, Santen Pharmaceutical Co., Ltd., Nara, Japan
- Noriko Odani-Kawabata
-
Roles Conceptualization, Writing – review & editing
Affiliation Product Development Division, Santen Pharmaceutical Co., Ltd., Osaka, Japan
- Ryo Iwamura
-
Roles Writing – review & editing
Affiliation Pharmaceutical Division, Pharmaceuticals Research Laboratory, UBE Corporation, Yamaguchi, Japan
- Kenji Yoneda
-
Roles Writing – review & editing
Affiliation Pharmaceutical Division, Pharmaceuticals Research Laboratory, UBE Corporation, Yamaguchi, Japan
- Masatomo Kato
-
Roles Conceptualization, Writing – review & editing
Affiliation Product Development Division, Santen Pharmaceutical Co., Ltd., Nara, Japan
Competing Interests
Competing Interests Statement: All authors declare no non-financial competing interests. Their commercial affiliation to Santen Pharmaceutical Co., Ltd. and UBE Corporation does not alter their adherence to PLOS ONE policies on sharing data and materials.